Monocyte Immunometabolic Axis Linking Type 2 Diabetes to Coronary Artery Disease Revealed by Multi-Omics Integration and Mendelian Randomization
Abstract
BACKGROUND: Type 2 diabetes (T2D) substantially increases coronary artery disease (CAD) risk, with residual risk unexplained by conventional factors. Immunometabolic dysregulation, particularly in monocytes, is implicated, but causal cell type-resolved evidence is limited. METHODS AND RESULTS: We integrated peripheral blood mononuclear cells' bulk and single-cell transcriptomes, identifying 1,799 differentially expressed genes enriched in immune and metabolic pathways. Two-sample Mendelian randomization identified 10 genes showing genetically predicted associations with both T2D and CAD. Among these, ADM, PGD, and ATG7 showed consistent genetically predicted associations with higher CAD risk. Single-cell analyses localized these genes to monocyte subsets and revealed enhanced intercellular communication with vascular cells. The genes also showed good discriminatory performance for CAD in T2D (AUCs 0.741-0.837). CONCLUSIONS: Multi-omics integration and genetic analyses supported a monocyte-centered immunometabolic framework involving ADM, PGD, and ATG7 that was consistent with elevated CAD risk in T2D, and generated testable hypotheses.
Related
- Targeting monocyte dysregulation in ovarian cancer: insights from single-cell genomics and Mendelian randomization.
- Association Between Genetically Predicted 25-Hydroxyvitamin D and Type 2 Diabetes Risk in South Asians: An Exploratory Two-Sample Mendelian Randomization Study.
- Protein mediators of chronic kidney disease in Type 2 diabetes: A mendelian randomization study
- Associations of Blood Lipid Traits with Cognitive-Related Outcomes and Their Sensitivity to APOE-Region Instrumental Variables: A Mendelian Randomization and Colocalization Study
- The relationship between genetic bone mineral density and spinal stenosis: a Mendelian randomization and cohort study
BibTeX
@article{zhai2026monocyte,
title = {{Monocyte Immunometabolic Axis Linking Type 2 Diabetes to Coronary Artery Disease Revealed by Multi-Omics Integration and Mendelian Randomization}},
author = {Min Zhai and Feng Bai and Rui Yan and Min Liu},
journal = {Circulation Journal},
year = {2026},
month = jul,
doi = {10.1253/circj.cj-25-1057},
url = {https://www.jstage.jst.go.jp/article/circj/90/8/90_CJ-25-1057/_article},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Monocyte Immunometabolic Axis Linking Type 2 Diabetes to Coronary Artery Disease Revealed by Multi-Omics Integration and Mendelian Randomization
AU - Min Zhai
AU - Feng Bai
AU - Rui Yan
AU - Min Liu
PY - 2026
DA - 2026/07/24
JO - Circulation Journal
DO - 10.1253/circj.cj-25-1057
UR - https://www.jstage.jst.go.jp/article/circj/90/8/90_CJ-25-1057/_article
AB - BACKGROUND: Type 2 diabetes (T2D) substantially increases coronary artery disease (CAD) risk, with residual risk unexplained by conventional factors. Immunometabolic dysregulation, particularly in monocytes, is implicated, but causal cell type-resolved evidence is limited. METHODS AND RESULTS: We integrated peripheral blood mononuclear cells' bulk and single-cell transcriptomes, identifying 1,799 differentially expressed genes enriched in immune and metabolic pathways. Two-sample Mendelian randomization identified 10 genes showing genetically predicted associations with both T2D and CAD. Among these, ADM, PGD, and ATG7 showed consistent genetically predicted associations with higher CAD risk. Single-cell analyses localized these genes to monocyte subsets and revealed enhanced intercellular communication with vascular cells. The genes also showed good discriminatory performance for CAD in T2D (AUCs 0.741-0.837). CONCLUSIONS: Multi-omics integration and genetic analyses supported a monocyte-centered immunometabolic framework involving ADM, PGD, and ATG7 that was consistent with elevated CAD risk in T2D, and generated testable hypotheses.
SN - 1347-4820
SN - 1346-9843
ER -